Surakit Pungpapong, M.D., studies viral hepatitis, both hepatitis B and C, and liver transplantation from the multiple viewpoints of epidemiology, natural history, diagnosis, treatment and prognosis. His research focuses include noninvasive assessment of liver fibrosis from viral hepatitis using serum markers and novel imaging technology such as magnetic resonance elastography; treatment of viral hepatitis before and after liver transplantation; impact of viral hepatitis on the outcome of liver transplantation; and how to improve the short-term and long-term outcomes of liver transplantation in patients with viral hepatitis.
- Treatment of hepatitis C in cirrhotic patients and liver transplant recipients
- Outcome of liver transplantation in patients with viral hepatitis
- Treatment and prevention of hepatitis B recurrence after liver transplantation
Significance to patient care
The goal of Dr. Pungpapong's research is to improve the outcome of liver transplantation in patients with viral hepatitis, both hepatitis B and C. His current ongoing research evaluates the efficacy and safety of new direct-acting antiviral agents to treat hepatitis C infection before and after liver transplantation.